# A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects

> **NCT03893045** · PHASE3 · RECRUITING · sponsor: **AMAG Pharmaceuticals, Inc.** · enrollment: 75 (estimated)

## Conditions studied

- Iron Deficiency Anemia

## Interventions

- **DRUG:** ferumoxytol
- **DRUG:** Iron sucrose

## Key facts

- **NCT ID:** NCT03893045
- **Lead sponsor:** AMAG Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-09-18
- **Primary completion:** 2026-07
- **Final completion:** 2026-10
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03893045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03893045, "A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03893045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*